Search research articles
Contact Us
Filters
Showing results (31-40 of 63) with videos related to
Page
of 7
Sort By:
Cancer Science
|
April 3, 2014
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor
Takayuki Nakagawa, Tomohiro Matsushima, Satoshi Kawano, et al.
Diabetes
|
October 27, 2004
Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet
Junji Matsui, Yasuo Terauchi, Naoto Kubota, et al.
Journal of Medicinal Chemistry
|
May 5, 2017
Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach
Yusuke Kamada, Nozomu Sakai, Satoshi Sogabe, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 29, 2017
Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors
Mariko Yoneyama-Hirozane, Kohei Deguchi, Takeshi Hirakawa, et al.
Cancer Science
|
September 5, 2017
Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models
Ken Ito, Shusei Hamamichi, Takanori Abe, et al.
The Journal of Biological Chemistry
|
December 21, 2002
Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice
Yasuo Terauchi, Junji Matsui, Ryo Suzuki, et al.
Cancer Science
|
November 18, 2018
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model
Takayuki Kimura, Yu Kato, Yoichi Ozawa, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
June 23, 2023
β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer
Eric R Reed, Stacy A Jankowski, Anthony J Spinella, et al.
Molecular Cancer Therapeutics
|
March 31, 2019
Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice
Rong Wang, Tadaaki Yamada, Sachiko Arai, et al.
Cell
|
December 1, 2014
Integration of genomic data enables selective discovery of breast cancer drivers
Félix Sanchez-Garcia, Patricia Villagrasa, Junji Matsui, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 63) with videos related to
Sort By:
Page
of 7
Cancer Science
|
April 3, 2014
Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor
Takayuki Nakagawa, Tomohiro Matsushima, Satoshi Kawano, et al.
Diabetes
|
October 27, 2004
Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet
Junji Matsui, Yasuo Terauchi, Naoto Kubota, et al.
Journal of Medicinal Chemistry
|
May 5, 2017
Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach
Yusuke Kamada, Nozomu Sakai, Satoshi Sogabe, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 29, 2017
Identification and Characterization of a New Series of Ghrelin O-Acyl Transferase Inhibitors
Mariko Yoneyama-Hirozane, Kohei Deguchi, Takeshi Hirakawa, et al.
Cancer Science
|
September 5, 2017
Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models
Ken Ito, Shusei Hamamichi, Takanori Abe, et al.
The Journal of Biological Chemistry
|
December 21, 2002
Impact of genetic background and ablation of insulin receptor substrate (IRS)-3 on IRS-2 knock-out mice
Yasuo Terauchi, Junji Matsui, Ryo Suzuki, et al.
Cancer Science
|
November 18, 2018
Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model
Takayuki Kimura, Yu Kato, Yoichi Ozawa, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
June 23, 2023
β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer
Eric R Reed, Stacy A Jankowski, Anthony J Spinella, et al.
Molecular Cancer Therapeutics
|
March 31, 2019
Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice
Rong Wang, Tadaaki Yamada, Sachiko Arai, et al.
Cell
|
December 1, 2014
Integration of genomic data enables selective discovery of breast cancer drivers
Félix Sanchez-Garcia, Patricia Villagrasa, Junji Matsui, et al.
Page
of 7